We are live on ! Find out more
GCTK icon

GlucoTrack

8 hedge funds and large institutions have $163K invested in GlucoTrack in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 88 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

73% less capital invested

Capital invested by funds: $594K → $163K (-$431K)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

GCTK Hedge Fund Activity: Q4 2023 in Review

8 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q4 2023, worth a combined $163K — down 73% from $594K a quarter earlier.

Fund positioning in GCTK was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $3.98K. The largest seller was Sabby Management, cutting an estimated $349K.

  • 8 institutional investors held GlucoTrack (GCTK) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $163K of GlucoTrack stock for Q4 2023, down 73% quarter-over-quarter.
  • 2 funds opened new GlucoTrack positions in Q4 2023 and 2 closed out, a net change of 0 holders.
  • The largest GlucoTrack buyer in Q4 2023 was Virtu Financial, an estimated $3.98K added.
  • The largest GlucoTrack seller in Q4 2023 was Sabby Management, an estimated $349K sold.

Based on aggregated 13F filings for Q4 2023.